Dialectical Behavioral Therapy in High Risk OrthopaedicTrauma Patients (OI-DBT)

March 23, 2020 updated by: Ida Leah Gitajn, Dartmouth-Hitchcock Medical Center
Psychological factors can affect the experience of pain and functional recovery from orthopedic injury. The purpose of this study is to examine the effect of brief Dialectical Behavior Therapy (DBT), a form of psychotherapy, on changing thoughts, feelings, and behaviors that can cause problems in daily living and interfere with recovery from orthopedic injury in patients who are at high risk for chronic pain and disability.

Study Overview

Status

Withdrawn

Conditions

Detailed Description

Musculoskeletal injuries represent one of the leading causes of hospital admissions for adults, and often results in long term pain, poor function, and permanent disability. Patients afflicted with musculoskeletal injuries contribute to an enormous cost to society in terms of direct health care spending, as well as indirect costs related to permanent disability, loss of work, and chronic pain contributing to the rising opioid epidemic. This is clearly a substantial and costly issue at Dartmouth-Hitchcock Medical Center (DHMC) as well as the country at large. From 2011 to 2017, 54% of patients who were admitted for fracture at DHMC had either a psychiatric diagnosis and/or a substance abuse diagnosis. It is likely that this number vastly underestimates the true amount of emotional distress present in this patient population because many patients with these issues do not carry formal psychiatric diagnoses. Diagnosis of psychiatric illness or substance abuse was associated with significantly higher resource utilization during hospital admission in terms of hospital length of stay (LOS, mean difference 3 days), need for ICU stay, number of consulting services, disposition to rehab, and rate of unplanned readmissions (21% versus 39%, respectively). Furthermore, this patient population had significantly higher mean pain score during admission and required 10-fold more opioids prescribed [measured in total morphine equivalents (MME)] and number of separate prescriptions needed.

These data within the investigator's own patient population reinforce the well documented reciprocal association between chronic pain and adverse mental health outcomes, such that pain triggers depression for example, but depression may as well exacerbate experiences of pain. In fact, catastrophic thinking about pain (tendency to assume the worst and believe that one will be unable to cope with the outcome), pain anxiety, and symptoms of depression are key factors that explain the magnitude of disability and pain intensity after musculoskeletal trauma. Resilience, the capacity to adapt to or recover from adversity, has been shown to attenuate the association between depression and pain. For this reason, the investigators believe it is important for patients to learn effective coping skills in order to effectively manage their pain and fear associated with recovering from a traumatic injury.

Dialectical Behavior Therapy (DBT) is a cognitive behavioral therapy that focuses on the balance between change and acceptance. DBT skills include four modules: two that enforce acceptance-oriented skills, mindfulness and distress tolerance, and two that promote change-oriented skills, interpersonal effectiveness and emotional regulation. This psychosocial treatment aims to reduce ineffective action tendencies associated with dysregulated emotions. DBT has been studied extensively in adult samples, across a wide range of settings. It has been shown to be effective in management of intense emotional states and development of coping skills in the most challenging patient populations including patients with Borderline Personality Disorder (BPD), eating disorders, and substance abuse. Furthermore, DBT-based interventions have demonstrated preliminary effectiveness in managing chronic pain and pain catastrophizing and anxiety. As such, patients with orthopedic trauma at high risk for chronic pain and disability would benefit from an evidence-based treatment approach that would teach them how to change thoughts, feelings, and behaviors that could cause problems in daily living and interfere with recovery from injury.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Hampshire
      • Lebanon, New Hampshire, United States, 03756
        • Dartmouth-Hitchcock

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age or older
  • Admitted to Dartmouth-Hitchcock Medical Center with an operatively treated fracture.

Exclusion Criteria:

  • Non-English speaking
  • Pain Catastrophizing Scale (PCS) score of < 13
  • Anticipating hospital length of stay of less than 2 days
  • Are expected to have severe problems maintaining follow-up and treatment recommendations
  • Have current or impending incarceration
  • Are actively psychotic or manic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard Care
No intervention - Standard care only. Group of 32 subjects
Experimental: Dialectical Behavioral Therapy
Dialectical Behavioral Therapy in addition to standard care. Four hour and a half group sessions (or one-on-one sessions, if not enough for a group session) commencing after surgery while still inpatient. Each session is designed to stand-alone, allowing for enrolling patients on a rolling basis.
Dialectical Behavior Therapy (DBT) is a cognitive behavioral therapy that focuses on the balance between change and acceptance. DBT skills include four modules: two that enforce acceptance-oriented skills, mindfulness and distress tolerance, and two that promote change-oriented skills, interpersonal effectiveness and emotional regulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change over time in Pain Severity: VAS
Time Frame: Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Visual Analogue Scale (VAS) Pain scores documented in the patient's medical record. Score Range 0-10. Higher score indicates greater pain.
Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Number of Opioids Administered
Time Frame: Hospital admission to hospital discharge, approximately 4-7 days
The opioids administered during hospitalization measured in total morphine equivalents
Hospital admission to hospital discharge, approximately 4-7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change over time in General Health Status
Time Frame: Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health: 10-item measure of physical and mental health. Scale range 0 to 100, mean 50, standard deviation 10. A higher score represents a better outcome.
Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Change over time in Psychological Functioning - Depression
Time Frame: Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Patient Health Questionnaire-9 (PHQ-9): 9-item measure of major depression symptom severity on a 4-point Likert-type scale. Score range 0-27; Higher score indicates more severe depressive symptoms.
Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Change over time in Psychological Functioning - PTSD
Time Frame: Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
PTSD Checklist for DSM-5 (PCL-5): 20-item measure of DSM-5 PTSD symptom severity on a 5-point Likert-type scale. Scale range 0-80. Higher score indicates more severe PTSD symptoms
Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Change over time in Pain Anxiety: PASS-20
Time Frame: Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Pain Anxiety Symptoms Scale (PASS-20): 20-item measure of pain anxiety on a 6-point Likert-type scale. Scale range 0-100. Higher score indicates more pain-related anxiety
Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Change over time in Pain Interference: BPI-SF
Time Frame: Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up
Brief Pain Inventory-Short Form (BPI-SF): 9-item measure of pain severity and impact of pain on daily functions. This is a 10-point scale with 0 being the best possible score, meaning "no pain", and 10 being the worst possible score, meaning "pain as bad as you can imagine".
Baseline, 2 week follow-up, 6-8 week follow-up, 10-14 week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2020

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

November 15, 2018

First Submitted That Met QC Criteria

December 14, 2018

First Posted (Actual)

December 17, 2018

Study Record Updates

Last Update Posted (Actual)

March 24, 2020

Last Update Submitted That Met QC Criteria

March 23, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Dialectical Behavioral Therapy

3
Subscribe